30,904 Shares in Petmed Express Inc (PETS) Purchased by Dupont Capital Management Corp

Share on StockTwits

Dupont Capital Management Corp purchased a new position in Petmed Express Inc (NASDAQ:PETS) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 30,904 shares of the company’s stock, valued at approximately $719,000. Dupont Capital Management Corp owned approximately 0.15% of Petmed Express as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. BlackRock Inc. boosted its holdings in shares of Petmed Express by 4.3% during the 3rd quarter. BlackRock Inc. now owns 3,042,857 shares of the company’s stock valued at $100,446,000 after purchasing an additional 125,194 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Petmed Express by 5.8% during the 3rd quarter. Renaissance Technologies LLC now owns 1,748,415 shares of the company’s stock valued at $57,715,000 after purchasing an additional 96,215 shares during the last quarter. Epoch Investment Partners Inc. boosted its holdings in shares of Petmed Express by 71.4% during the 3rd quarter. Epoch Investment Partners Inc. now owns 857,722 shares of the company’s stock valued at $28,313,000 after purchasing an additional 357,304 shares during the last quarter. Penserra Capital Management LLC boosted its holdings in shares of Petmed Express by 20.2% during the 3rd quarter. Penserra Capital Management LLC now owns 485,493 shares of the company’s stock valued at $16,026,000 after purchasing an additional 81,648 shares during the last quarter. Finally, Copeland Capital Management LLC boosted its holdings in shares of Petmed Express by 15.2% during the 4th quarter. Copeland Capital Management LLC now owns 387,823 shares of the company’s stock valued at $9,020,000 after purchasing an additional 51,283 shares during the last quarter. Institutional investors and hedge funds own 98.93% of the company’s stock.

Shares of NASDAQ:PETS opened at $23.41 on Thursday. Petmed Express Inc has a 12 month low of $20.25 and a 12 month high of $48.32. The stock has a market capitalization of $479.02 million, a P/E ratio of 11.13 and a beta of 0.55.

Petmed Express (NASDAQ:PETS) last announced its quarterly earnings results on Tuesday, January 22nd. The company reported $0.38 EPS for the quarter, missing the Zacks’ consensus estimate of $0.48 by ($0.10). Petmed Express had a net margin of 14.43% and a return on equity of 32.89%. The business had revenue of $60.10 million during the quarter, compared to the consensus estimate of $64.22 million. During the same period in the previous year, the business posted $0.44 EPS. The firm’s revenue was up .0% on a year-over-year basis.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 15th. Investors of record on Monday, February 4th will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 4.61%. The ex-dividend date of this dividend is Friday, February 1st.

Several research analysts have commented on PETS shares. ValuEngine downgraded shares of Petmed Express from a “hold” rating to a “sell” rating in a report on Monday, February 4th. Craig Hallum lowered their price target on shares of Petmed Express from $25.00 to $18.00 and set a “sell” rating for the company in a report on Wednesday, January 23rd. BidaskClub raised shares of Petmed Express from a “strong sell” rating to a “sell” rating in a report on Saturday, December 22nd. Finally, TheStreet downgraded shares of Petmed Express from a “b” rating to a “c+” rating in a report on Thursday, November 29th. Three equities research analysts have rated the stock with a sell rating and two have given a hold rating to the company’s stock. Petmed Express currently has a consensus rating of “Sell” and a consensus target price of $28.00.

WARNING: This news story was first reported by BBNS and is the property of of BBNS. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://baseballnewssource.com/2019/02/14/30904-shares-in-petmed-express-inc-pets-purchased-by-dupont-capital-management-corp/3214927.html.

About Petmed Express

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Featured Article: What are Closed-End Mutual Funds?

Institutional Ownership by Quarter for Petmed Express (NASDAQ:PETS)

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2019 BBNS.